MyFinsight
Home
Blog
About
Cash and cash
equivalents
$155,548K
(13.28%↑ Y/Y)
Accounts receivable, net
$53,506K
(-26.51%↓ Y/Y)
Inventories
$13,018K
(-22.09%↓ Y/Y)
Prepaid expenses and
other current assets
$7,481K
(-4.48%↓ Y/Y)
Total current assets
$229,553K
(-2.18%↓ Y/Y)
Goodwill
$59,044K
(0.00%↑ Y/Y)
Other long-term
assets
$53,747K
(21.62%↑ Y/Y)
Operating right-of-use
assets
$5,800K
(-3.12%↓ Y/Y)
Property and equipment,
net
$1,514K
(-11.67%↓ Y/Y)
Total assets
$349,658K
(1.18%↑ Y/Y)
Total liabilities and
stockholders' equity
$349,658K
(1.18%↑ Y/Y)
Total liabilities
$324,640K
(2.61%↑ Y/Y)
Total stockholders'
equity
$25,018K
(-14.39%↓ Y/Y)
Accumulated deficit
-$1,701,667K
(-1.77%↓ Y/Y)
Total current
liabilities
$160,865K
(35.50%↑ Y/Y)
Liability related to
settlement royalties, net...
$60,848K
(24.87%↑ Y/Y)
Liability related to sale
of future...
$50,034K
(-2.05%↓ Y/Y)
Long-term debt, net of
current portion
$24,754K
(-47.40%↓ Y/Y)
Working capital fund
liability, net of current...
$21,219K
(-30.56%↓ Y/Y)
Long-term operating lease
liabilities
$4,400K
(555.74%↑ Y/Y)
Warrant liability
$1,958K
(-86.21%↓ Y/Y)
Other long-term
liabilities
$562K
(-89.51%↓ Y/Y)
Additional paid-in capital
$1,726,677K
(1.50%↑ Y/Y)
Accumulated other
comprehensive income
$6K
(0.00%↑ Y/Y)
Common stock 0.00001
par value...
$2K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$109,797K
(19.85%↑ Y/Y)
Current portion of
long-term debt
$24,809K
Working capital fund
liability, current portion
$10,668K
(6.51%↑ Y/Y)
Accounts payable
$9,422K
(-18.45%↓ Y/Y)
Current portion of
deferred revenue
$6,169K
(11.51%↑ Y/Y)
Back
Back
Balance Sheet
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)
source: myfinsight.com